Rankings
▼
Calendar
ANIK (Anika Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
Mkt Cap
$213M
Healthcare
·
Medical - Devices
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$113M
Net Income (TTM)
-$11M
EPS (TTM)
-$0.76
Free Cash Flow (TTM)
$4M
Gross Margin
56.6%
Op. Margin
-9.8%
Net Margin
-9.6%
FCF Margin
3.9%
P/S Ratio (TTM)
1.9x
P/E Ratio (TTM)
—
YoY Rev Growth
+3.8%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$38M
$23M
-$13M
Q2 23
$44M
$29M
-$4M
Q3 23
$41M
$25M
-$8M
Q4 23
$43M
$26M
-$64M
Q1 24
$41M
$25M
-$5M
Q2 24
$31M
$20M
-$2M
Q3 24
$39M
$1M
-$28M
Q4 24
-$1M
$23M
$28M
Q1 25
$26M
$15M
-$4M
Q2 25
$28M
$14M
-$4M
Q3 25
$28M
$16M
-$3M
Q4 25
$31M
$19M
$646K
marketcaparena.com
Revenue Breakdown
ANIK
Anika Therapeutics, Inc.
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
1.4x
—
Q2 23
1.3x
—
Q3 23
1.3x
—
Q4 23
1.3x
—
Q1 24
1.3x
—
Q2 24
1.4x
—
Q3 24
1.4x
—
Q4 24
2.0x
—
Q1 25
2.3x
—
Q2 25
2.3x
—
Q3 25
2.6x
—
Q4 25
1.9x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$4M
-$5M
Q2 23
-$8M
-$10M
Q3 23
$6M
$6M
Q4 23
$4M
$2M
Q1 24
-$126K
-$2M
Q2 24
-$1M
-$4M
Q3 24
$5M
$3M
Q4 24
$2M
$275K
Q1 25
-$130K
-$3M
Q2 25
-$189K
-$2M
Q3 25
$7M
$5M
Q4 25
$5M
$4M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$1M
Q2 23
$1M
Q3 23
$741K
Q4 23
$2M
Q1 24
$2M
Q2 24
$3M
Q3 24
$2M
Q4 24
$1M
Q1 25
$3M
Q2 25
$1M
Q3 25
$2M
Q4 25
$648K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+3.4%
+25.4%
Q2 23
+11.7%
+11.4%
Q3 23
+3.0%
+6.7%
Q4 23
+8.5%
+130.6%
Q1 24
+6.9%
-9.7%
Q2 24
-30.6%
-32.1%
Q3 24
-6.5%
+35.9%
Q4 24
-103.0%
-127.3%
Q1 25
-35.4%
-33.2%
Q2 25
-8.2%
-0.4%
Q3 25
-28.2%
-53.5%
Q4 25
+2473.3%
+203.0%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$4M
9.8%
Q2 23
$0
0.0%
Q3 23
$4M
8.6%
Q4 23
$4M
8.9%
Q1 24
$0
0.0%
Q2 24
$4M
12.7%
Q3 24
$3M
8.8%
Q4 24
$2M
—
Q1 25
$3M
10.9%
Q2 25
$3M
9.0%
Q3 25
$2M
8.0%
Q4 25
$2M
8.0%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$8M
$27M
Q2 23
$9M
$24M
Q3 23
$8M
$25M
Q4 23
$8M
$20M
Q1 24
$8M
$22M
Q2 24
$7M
$16M
Q3 24
$7M
$19M
Q4 24
$3M
—
Q1 25
$6M
$13M
Q2 25
$6M
$12M
Q3 25
$7M
$12M
Q4 25
$6M
$12M
marketcaparena.com
Revenue Segments
Joint Preservation and Restoration
Non-Orthopedic
OA Pain Management
Quarter
Joint Preservation and Restoration
Non-Orthopedic
OA Pain Management
Q1 23
$13M
$2M
$23M
Q2 23
$13M
$2M
$29M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$80M
$0
$80M
Q2 23
$65M
$0
$65M
Q3 23
$71M
$0
$71M
Q4 23
$69M
$0
$69M
Q1 24
$69M
$0
$69M
Q2 24
$63M
$0
$63M
Q3 24
$62M
$0
$62M
Q4 24
$56M
$0
$56M
Q1 25
$53M
$0
$53M
Q2 25
$53M
$0
$53M
Q3 25
$58M
$0
$58M
Q4 25
$57M
$0
$57M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
15M
+0.1%
Q2 23
15M
+0.2%
Q3 23
15M
-0.4%
Q4 23
15M
+0.1%
Q1 24
15M
+0.3%
Q2 24
15M
+1.0%
Q3 24
15M
-0.5%
Q4 24
15M
-0.3%
Q1 25
14M
-2.9%
Q2 25
14M
+0.2%
Q3 25
14M
+0.2%
Q4 25
15M
+2.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$1M
105
FY 15
$869K
107
FY 16
$847K
122
FY 17
$922K
123
FY 18
$794K
133
FY 19
$744K
154
FY 20
$471K
277
FY 21
$498K
297
FY 22
$330K
345
FY 23
$338K
357
FY 24
$416K
288
FY 25
$480K
235
marketcaparena.com